{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:00:18Z","timestamp":1789999218712,"version":"4.0.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Capitals Funds for Health Improvement and Research","award":["2024-2-5094"],"award-info":[{"award-number":["2024-2-5094"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-05300-4","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:06:38Z","timestamp":1782907598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential analysis of the lower respiratory tract microbiota between patients with non-tuberculous mycobacterial pulmonary disease and pulmonary tuberculosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jie","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"5300_CR1","doi-asserted-by":"publisher","first-page":"1468383","DOI":"10.3389\/fmicb.2024.1468383","volume":"15","author":"K Takeda","year":"2024","unstructured":"Takeda K, Takazono T, Mukae H. Drug-drug interactions in the management of non-tuberculous mycobacterial infections. Front Microbiol. 2024;15:1468383. https:\/\/doi.org\/10.3389\/fmicb.2024.1468383.","journal-title":"Front Microbiol"},{"key":"5300_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fpubh.2020.00295","volume":"8","author":"L Zhou","year":"2020","unstructured":"Zhou L, Xu D, Liu H, et al. Trends in the prevalence and antibiotic resistance of non-tuberculous mycobacteria in mainland China, 2000-2019: systematic review and meta-analysis. Front Public Health. 2020;8:295. https:\/\/doi.org\/10.3389\/fpubh.2020.00295.","journal-title":"Front Public Health"},{"key":"5300_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.19982\/j.issn.1000-6621.20220515","volume":"45","author":"H Duan","year":"2023","unstructured":"Duan H. Stay updated on research to enhance treatment of nontuberculous mycobacterial diseases. Chin J Antituberc. 2023;45:329\u201332. https:\/\/doi.org\/10.19982\/j.issn.1000-6621.20220515.","journal-title":"Chin J Antituberc"},{"key":"5300_CR4","doi-asserted-by":"publisher","first-page":"111064","DOI":"10.1016\/j.intimp.2023.111064","volume":"124 Pt B","author":"Q Liu","year":"2023","unstructured":"Liu Q, Pan X, An H, et al. Building a model for the differential diagnosis of non-tuberculous mycobacterial lung disease and pulmonary tuberculosis: A case-control study based on immunological and radiological features. Int Immunopharmacol. 2023;124 Pt B:111064. https:\/\/doi.org\/10.1016\/j.intimp.2023.111064.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5300_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-020-00667-6","volume":"27","author":"R Gopalaswamy","year":"2020","unstructured":"Gopalaswamy R, Shanmugam S, Mondal R, et al. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 2020;27(1):74. https:\/\/doi.org\/10.1186\/s12929-020-00667-6.","journal-title":"J Biomed Sci"},{"issue":"1","key":"5300_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21307\/pjm-2019-002","volume":"68","author":"E Augustynowicz-Kope\u0107","year":"2019","unstructured":"Augustynowicz-Kope\u0107 E, Siemion-Szcze\u015bniak I, Zabost A, et al. Interferon gamma release assays in patients with respiratory isolates of non-tuberculous mycobacteria - a preliminary study. Pol J Microbiol. 2019;68(1):15\u20139. https:\/\/doi.org\/10.21307\/pjm-2019-002.","journal-title":"Pol J Microbiol"},{"issue":"7","key":"5300_CR7","doi-asserted-by":"publisher","first-page":"e0092225","DOI":"10.1128\/spectrum.00922-25","volume":"13","author":"X Lei","year":"2025","unstructured":"Lei X, Xu X, Liu C, et al. Clinical evaluation of two pathogen enrichment approaches for next-generation sequencing in the diagnosis of lower respiratory tract infections. Microbiol Spectr. 2025;13(7):e0092225. https:\/\/doi.org\/10.1128\/spectrum.00922-25.","journal-title":"Microbiol Spectr"},{"key":"5300_CR8","doi-asserted-by":"publisher","first-page":"1439472","DOI":"10.3389\/fcimb.2024.1439472","volume":"14","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wu W, Xiao Y, et al. Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients. Front Cell Infect Microbiol. 2024;14:1439472. https:\/\/doi.org\/10.3389\/fcimb.2024.1439472.","journal-title":"Front Cell Infect Microbiol"},{"key":"5300_CR9","doi-asserted-by":"publisher","first-page":"105722","DOI":"10.1016\/j.meegid.2025.105722","volume":"128","author":"H Da","year":"2025","unstructured":"Da H, Meng T, Xu Y. Application of targeted next-generation sequencing for detecting respiratory pathogens in the sputum of patients with pulmonary infections. Infect Genet Evol. 2025;128:105722. https:\/\/doi.org\/10.1016\/j.meegid.2025.105722.","journal-title":"Infect Genet Evol"},{"key":"5300_CR10","doi-asserted-by":"publisher","unstructured":"Chen Z, Liu X, Tan L, et al. Comparative of metagenomic and targeted next-generation sequencing in lower respiratory tract fungal infections. Front Cell Infect Microbiol. 2025;15(1534519). https:\/\/doi.org\/10.3389\/fcimb.2025.1534519.","DOI":"10.3389\/fcimb.2025.1534519"},{"key":"5300_CR11","doi-asserted-by":"publisher","first-page":"1227581","DOI":"10.3389\/fcimb.2023.1227581","volume":"13","author":"D Zhan","year":"2023","unstructured":"Zhan D, Li D, Yuan K, et al. Characteristics of the pulmonary microbiota in patients with mild and severe pulmonary infection. Front Cell Infect Microbiol. 2023;13:1227581. https:\/\/doi.org\/10.3389\/fcimb.2023.1227581.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"5300_CR12","doi-asserted-by":"publisher","first-page":"13179","DOI":"10.1038\/s41598-025-96746-5","volume":"15","author":"K Bahetjan","year":"2025","unstructured":"Bahetjan K, Yu X, Lin S, et al. Analysis of the bronchoalveolar lavage fluid microbial flora in COPD patients at different lung function during acute exacerbation. Sci Rep. 2025;15(1):13179. https:\/\/doi.org\/10.1038\/s41598-025-96746-5.","journal-title":"Sci Rep"},{"key":"5300_CR13","doi-asserted-by":"publisher","unstructured":"Jang JG, Lee H, Kang MG, et al. Chronic obstructive pulmonary disease is a risk factor for non-tuberculous mycobacterial pulmonary disease: a population-based matched cohort study. BMJ Open Respir Res. 2025;12(1). https:\/\/doi.org\/10.1136\/bmjresp-2024-002373.","DOI":"10.1136\/bmjresp-2024-002373"},{"issue":"2","key":"5300_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3760\/cma.j.cn112147-20240808-00471","volume":"48","author":"Chinese Society of Tuberculosis, Chinese Medical Association; Chinese Throacic Society, Chinese Medical Association","year":"2025","unstructured":"Chinese Society of Tuberculosis, Chinese Medical Association; Chinese Throacic Society, Chinese Medical Association. Chinese expert consensus on diagnosis and treatment of non-tuberculous mycobacterial pulmonary disease complicated with bronchiectasis. Chin J Tuberc Respir Dis. 2025;48(2):101\u201315. https:\/\/doi.org\/10.3760\/cma.j.cn112147-20240808-00471.","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"1","key":"5300_CR15","doi-asserted-by":"publisher","first-page":"e0190121","DOI":"10.1128\/spectrum.01901-21","volume":"10","author":"G Xiao","year":"2022","unstructured":"Xiao G, Cai Z, Guo Q, et al. Insights into the unique lung microbiota profile of pulmonary tuberculosis patients using metagenomic next-generation sequencing. Microbiol Spectr. 2022;10(1):e0190121. https:\/\/doi.org\/10.1128\/spectrum.01901-21.","journal-title":"Microbiol Spectr"},{"key":"5300_CR16","doi-asserted-by":"publisher","first-page":"1083497","DOI":"10.3389\/fcimb.2022.1083497","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Xu H, Wang X, et al. Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals. Front Cell Infect Microbiol. 2022;12:1083497. https:\/\/doi.org\/10.3389\/fcimb.2022.1083497.","journal-title":"Front Cell Infect Microbiol"},{"key":"5300_CR17","doi-asserted-by":"publisher","first-page":"898195","DOI":"10.3389\/fmicb.2022.898195","volume":"13","author":"P Xu","year":"2022","unstructured":"Xu P, Yang K, Yang L, et al. Next-generation metagenome sequencing shows superior diagnostic performance in acid-fast staining sputum smear-negative pulmonary tuberculosis and non-tuberculous mycobacterial pulmonary disease. Front Microbiol. 2022;13:898195. https:\/\/doi.org\/10.3389\/fmicb.2022.898195.","journal-title":"Front Microbiol"},{"issue":"09","key":"5300_CR18","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.19982\/j.issn.1000-6621.20240179","volume":"46","author":"F Wang","year":"2024","unstructured":"Wang F, Guo DH. Characteristic analysis of non-tuberculous mycobacterial pulmonary disease patients in Wuhan area from 2021 to 2023. Chin J Antituberc. 2024;46(09):1069\u201376. https:\/\/doi.org\/10.19982\/j.issn.1000-6621.20240179.","journal-title":"Chin J Antituberc"},{"key":"5300_CR19","doi-asserted-by":"publisher","first-page":"1320831","DOI":"10.3389\/fcimb.2024.1320831","volume":"14","author":"R Hong","year":"2024","unstructured":"Hong R, Lin S, Zhang S, et al. Pathogen spectrum and microbiome in lower respiratory tract of patients with different pulmonary diseases based on metagenomic next-generation sequencing. Front Cell Infect Microbiol. 2024;14:1320831. https:\/\/doi.org\/10.3389\/fcimb.2024.1320831.","journal-title":"Front Cell Infect Microbiol"},{"key":"5300_CR20","doi-asserted-by":"publisher","unstructured":"Mac Aog\u00e1in M, Dicker AJ, Mertsch P, et al. Infection and the microbiome in bronchiectasis. Eur Respir Rev. 2024;33(173). https:\/\/doi.org\/10.1183\/16000617.0038-2024.","DOI":"10.1183\/16000617.0038-2024"},{"key":"5300_CR21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3760\/cma.j.cn112147-20200508-00570","volume":"43","author":"Chinese Society of Tuberculosis, Chinese Medical Association","year":"2020","unstructured":"Chinese Society of Tuberculosis, Chinese Medical Association. Guidelines for diagnosis and treatment of non-tuberculous mycobacterial diseases (2020 Edition). Chin J Tuberc Respir Dis. 2020;43:918\u201346. https:\/\/doi.org\/10.3760\/cma.j.cn112147-20200508-00570.","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"1","key":"5300_CR22","first-page":"59","volume":"3","author":"China","year":"2018","unstructured":"China, National Health and Family Planning Commission of the People\u2032s. Republic of. Diagnostic criteria for tuberculosis (WS 288\u20132017). Electron J Emerg Infect Dis. 2018;3(1):59\u201361.","journal-title":"Electron J Emerg Infect Dis"},{"key":"5300_CR23","doi-asserted-by":"publisher","first-page":"1344162","DOI":"10.3389\/fmicb.2024.1344162","volume":"15","author":"J Mi","year":"2024","unstructured":"Mi J, Liu Y, Xue Y, et al. The changes and its significance of peripheral blood NK cells in patients with tuberculous meningitis. Front Microbiol. 2024;15:1344162. https:\/\/doi.org\/10.3389\/fmicb.2024.1344162.","journal-title":"Front Microbiol"},{"issue":"19","key":"5300_CR24","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.21037\/atm-21-4031","volume":"9","author":"K Xu","year":"2021","unstructured":"Xu K, Miao L, Chen W, et al. Establishment of the reference intervals of lymphocyte subsets for healthy Chinese Han adults and its influencing factors. Ann Transl Med. 2021;9(19):1495. https:\/\/doi.org\/10.21037\/atm-21-4031.","journal-title":"Ann Transl Med"},{"key":"5300_CR25","unstructured":"Yingying L. Analysis of clinical characteristics of non-tuberculous Mycobacterial pulmonary disease and pulmonary tuberculosis. Huazhong University of Science and Technology; 2023."},{"issue":"11","key":"5300_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.ajic.2019.04.171","volume":"47","author":"E Klann","year":"2019","unstructured":"Klann E, Beal SG, Tremblay EE. Evaluating differences in tuberculosis and nontuberculous mycobacterial lung disease in Florida. Am J Infect Control. 2019;47(11):1324\u20138. https:\/\/doi.org\/10.1016\/j.ajic.2019.04.171.","journal-title":"Am J Infect Control"},{"issue":"6","key":"5300_CR27","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/rct.0000000000001368","volume":"46","author":"J Zhang","year":"2022","unstructured":"Zhang J, Yang Y. Computed tomography comparative analysis of nontuberculous mycobacterial lung disease in the elderly and secondary pulmonary tuberculosis. J Comput Assist Tomogr. 2022;46(6):884\u20137. https:\/\/doi.org\/10.1097\/rct.0000000000001368.","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"5300_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.19871\/j.cnki.xfcrbzz.2020.02.011","volume":"5","author":"J Xu","year":"2020","unstructured":"Xu J, Zhang X, Chen Z. Comparative analysis of CT findings between non-tuberculous mycobacterial pulmonary disease and secondary pulmonary tuberculosis. Elect J Emerg Infect Dis. 2020;5(2):113\u20137. https:\/\/doi.org\/10.19871\/j.cnki.xfcrbzz.2020.02.011.","journal-title":"Elect J Emerg Infect Dis"},{"issue":"3","key":"5300_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.resinv.2019.12.006","volume":"58","author":"K Miura","year":"2020","unstructured":"Miura K, Nakamura M, Taooka Y, et al. Comparison of the chest computed tomography findings between patients with pulmonary tuberculosis and those with Mycobacterium avium complex lung disease. Respir Investig. 2020;58(3):137\u201343. https:\/\/doi.org\/10.1016\/j.resinv.2019.12.006.","journal-title":"Respir Investig"},{"issue":"5","key":"5300_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.5588\/ijtld.10.0485","volume":"15","author":"SW Ra","year":"2011","unstructured":"Ra SW, Lyu J, Choi CM, et al. Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay. Int J Tuberc Lung Dis. 2011;15(5):635\u201340. https:\/\/doi.org\/10.5588\/ijtld.10.0485.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5300_CR31","doi-asserted-by":"publisher","first-page":"571230","DOI":"10.3389\/fcimb.2020.571230","volume":"10","author":"C Yang","year":"2020","unstructured":"Yang C, Luo X, Fan L, et al. Performance of interferon-gamma release assays in the diagnosis of nontuberculous mycobacterial diseases-a retrospective survey from 2011 to 2019. Front Cell Infect Microbiol. 2020;10:571230. https:\/\/doi.org\/10.3389\/fcimb.2020.571230.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"5300_CR32","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3201\/eid2307.162033","volume":"23","author":"Y Chen","year":"2017","unstructured":"Chen Y, Jiang J, Jiang H, et al. Mycobacterium gordonae in patient with facial ulcers, nosebleeds, and positive T-SPOT.TB test, China. Emerg Infect Dis. 2017;23(7):1204\u20136. https:\/\/doi.org\/10.3201\/eid2307.162033.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"5300_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1040638718824074","volume":"31","author":"S Scherrer","year":"2019","unstructured":"Scherrer S, Landolt P, Friedel U, et al. Distribution and expression of esat-6 and cfp-10 in non-tuberculous mycobacteria isolated from lymph nodes of slaughtered cattle in Switzerland. J Vet Diagn Invest. 2019;31(2):217\u201321. https:\/\/doi.org\/10.1177\/1040638718824074.","journal-title":"J Vet Diagn Invest"},{"issue":"5","key":"5300_CR34","doi-asserted-by":"publisher","first-page":"20230138","DOI":"10.1002\/exp.20230138","volume":"4","author":"Z Ye","year":"2024","unstructured":"Ye Z, Li L, Yang L, et al. Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective. Explor (Beijing). 2024;4(5):20230138. https:\/\/doi.org\/10.1002\/exp.20230138.","journal-title":"Explor (Beijing)"},{"issue":"40","key":"5300_CR35","doi-asserted-by":"publisher","first-page":"e44861","DOI":"10.1097\/md.0000000000044861","volume":"104","author":"S Gegin","year":"2025","unstructured":"Gegin S, Pazarli AC, \u00d6zdemir B, et al. The role of systemic inflammatory markers in differentiating tuberculosis from nontuberculous mycobacterial colonization and infection: A retrospective observational study. Med (Baltim). 2025;104(40):e44861. https:\/\/doi.org\/10.1097\/md.0000000000044861.","journal-title":"Med (Baltim)"},{"issue":"1","key":"5300_CR36","doi-asserted-by":"publisher","first-page":"2409965","DOI":"10.1080\/07853890.2024.2409965","volume":"56","author":"Q Yu","year":"2024","unstructured":"Yu Q, Hu S, Liu F, et al. A novel hematological score (HS) and its related nomogram model to predict nontuberculous mycobacterial pulmonary disease in patients with suspected multidrug-resistant pulmonary tuberculosis. Ann Med. 2024;56(1):2409965. https:\/\/doi.org\/10.1080\/07853890.2024.2409965.","journal-title":"Ann Med"},{"issue":"3","key":"5300_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.tube.2015.03.004","volume":"95","author":"YS Kwon","year":"2015","unstructured":"Kwon YS, Cho YN, Kim MJ, et al. Mucosal-associated invariant T cells are numerically and functionally deficient in patients with mycobacterial infection and reflect disease activity. Tuberculosis (Edinb). 2015;95(3):267\u201374. https:\/\/doi.org\/10.1016\/j.tube.2015.03.004.","journal-title":"Tuberculosis (Edinb)"},{"issue":"17","key":"5300_CR38","doi-asserted-by":"publisher","first-page":"e37434","DOI":"10.1016\/j.heliyon.2024.e37434","volume":"10","author":"X Li","year":"2024","unstructured":"Li X, Sun D, Liang C, et al. Characterization of non-tuberculous mycobacterial pulmonary disease and pulmonary tuberculosis in patients with AFB smear-positive sputum: A retrospective comparative study. Heliyon. 2024;10(17):e37434. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37434.","journal-title":"Heliyon"},{"issue":"3","key":"5300_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.chest.2021.10.003","volume":"161","author":"K Kumar","year":"2022","unstructured":"Kumar K, Loebinger MR. Nontuberculous mycobacterial pulmonary disease: clinical epidemiologic features, risk factors, and diagnosis: the nontuberculous mycobacterial series. Chest. 2022;161(3):637\u201346. https:\/\/doi.org\/10.1016\/j.chest.2021.10.003.","journal-title":"Chest"},{"issue":"6","key":"5300_CR40","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1053\/j.semdp.2017.06.002","volume":"34","author":"AC Roden","year":"2017","unstructured":"Roden AC, Schuetz AN. Histopathology of fungal diseases of the lung. Semin Diagn Pathol. 2017;34(6):530\u201349. https:\/\/doi.org\/10.1053\/j.semdp.2017.06.002.","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"5300_CR41","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd;, Denning DW, et al. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1\u201360. https:\/\/doi.org\/10.1093\/cid\/ciw326.","journal-title":"Clin Infect Dis"},{"key":"5300_CR42","unstructured":"Huang Z. Study on the distribution of etiological and changes of drug resistance in adult patients with bronchiectasis accompanied with infection. FuJian Medical University; 2023."},{"key":"5300_CR43","doi-asserted-by":"publisher","first-page":"128039","DOI":"10.1016\/j.micres.2024.128039","volume":"292","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun X, Lin Y, et al. Stealth in non-tuberculous mycobacteria: clever challengers to the immune system. Microbiol Res. 2025;292:128039. https:\/\/doi.org\/10.1016\/j.micres.2024.128039.","journal-title":"Microbiol Res"},{"key":"5300_CR44","doi-asserted-by":"publisher","unstructured":"Dewi IMW, van de Veerdonk FL, Gresnigt MS. The multifaceted role of T-helper responses in host defense against Aspergillus fumigatus. J Fungi (Basel). 2017;3(4). https:\/\/doi.org\/10.3390\/jof3040055.","DOI":"10.3390\/jof3040055"},{"key":"5300_CR45","doi-asserted-by":"publisher","unstructured":"Lyadova IV, Panteleev AV. Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers. Mediators Inflamm 2015. 2015;854507. https:\/\/doi.org\/10.1155\/2015\/854507.","DOI":"10.1155\/2015\/854507"},{"issue":"11","key":"5300_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro.2017.90","volume":"15","author":"FL van de Veerdonk","year":"2017","unstructured":"van de Veerdonk FL, Gresnigt MS, Romani L, et al. Aspergillus fumigatus morphology and dynamic host interactions. Nat Rev Microbiol. 2017;15(11):661\u201374. https:\/\/doi.org\/10.1038\/nrmicro.2017.90.","journal-title":"Nat Rev Microbiol"},{"key":"5300_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-025-01180-z","author":"FL van de Veerdonk","year":"2025","unstructured":"van de Veerdonk FL, Carvalho A, Wauters J, et al. Aspergillus fumigatus biology, immunopathogenicity and drug resistance. Nat Rev Microbiol. 2025. https:\/\/doi.org\/10.1038\/s41579-025-01180-z.","journal-title":"Nat Rev Microbiol"},{"key":"5300_CR48","doi-asserted-by":"publisher","unstructured":"Ramakrishnan AM, Jayapradha. Virulence and pathogenicity of secondary fungal infections. Crit Rev Microbiol. 2025;1\u201320. https:\/\/doi.org\/10.1080\/1040841X.2025.2537423.","DOI":"10.1080\/1040841X.2025.2537423"},{"issue":"8","key":"5300_CR49","doi-asserted-by":"publisher","first-page":"101114","DOI":"10.1016\/j.lanmic.2025.101114","volume":"6","author":"Y Song","year":"2025","unstructured":"Song Y, Buil JB, Rhodes J, et al. Triazole-resistant Aspergillus fumigatus in the Netherlands between 1994 and 2022: a genomic and phenotypic study. Lancet Microbe. 2025;6(8):101114. https:\/\/doi.org\/10.1016\/j.lanmic.2025.101114.","journal-title":"Lancet Microbe"},{"key":"5300_CR50","doi-asserted-by":"publisher","first-page":"1550724","DOI":"10.3389\/fimmu.2025.1550724","volume":"16","author":"SQ Lew","year":"2025","unstructured":"Lew SQ, Chong SY, Lau GW. Modulation of pulmonary immune functions by the Pseudomonas aeruginosa secondary metabolite pyocyanin. Front Immunol. 2025;16:1550724. https:\/\/doi.org\/10.3389\/fimmu.2025.1550724.","journal-title":"Front Immunol"},{"issue":"1","key":"5300_CR51","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1038\/s41467-018-05004-y","volume":"9","author":"F Wang","year":"2018","unstructured":"Wang F, He Q, Yin J, et al. BrlR from Pseudomonas aeruginosa is a receptor for both cyclic di-GMP and pyocyanin. Nat Commun. 2018;9(1):2563. https:\/\/doi.org\/10.1038\/s41467-018-05004-y.","journal-title":"Nat Commun"},{"key":"5300_CR52","doi-asserted-by":"publisher","unstructured":"Bhat TA, Panzica L, Kalathil SG et al. Immune dysfunction in patients with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2015, 12 Suppl 2 (Suppl 2), S169-175. https:\/\/doi.org\/10.1513\/AnnalsATS.201503-126AW","DOI":"10.1513\/AnnalsATS.201503-126AW"},{"issue":"9","key":"5300_CR53","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.4103\/0366-6999.230743","volume":"131","author":"GD Amatngalim","year":"2018","unstructured":"Amatngalim GD, Hiemstra PS. Airway epithelial cell function and respiratory host defense in Chronic Obstructive Pulmonary Disease. Chin Med J (Engl). 2018;131(9):1099\u2013107. https:\/\/doi.org\/10.4103\/0366-6999.230743.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"5300_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4269\/ajtmh.16-1004","volume":"97","author":"S Hatakeyama","year":"2017","unstructured":"Hatakeyama S, Yamashita T, Sakai T, et al. Case report: disseminated Talaromyces (Penicillium) marneffei and Mycobacterium tuberculosis coinfection in a Japanese patient with acquired immunodeficiency syndrome. Am J Trop Med Hyg. 2017;97(1):38\u201341. https:\/\/doi.org\/10.4269\/ajtmh.16-1004.","journal-title":"Am J Trop Med Hyg"},{"key":"5300_CR55","doi-asserted-by":"publisher","DOI":"10.17511\/jopm.2019.i11.20","author":"M Chalana","year":"2019","unstructured":"Chalana M, Oberoi L. Talaromyces (Penicillium) marneffei and Mycobacterium tuberculosis coinfection in a HIV negative patient in Amritsar Punjab, India. Trop J Pathol Microbiol. 2019. https:\/\/doi.org\/10.17511\/jopm.2019.i11.20.","journal-title":"Trop J Pathol Microbiol"},{"issue":"3","key":"5300_CR56","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/s1473-3099(24)00567-x","volume":"25","author":"A Sengupta","year":"2025","unstructured":"Sengupta A, Ray A, Upadhyay AD, et al. Mortality in chronic pulmonary aspergillosis: a systematic review and individual patient data meta-analysis. Lancet Infect Dis. 2025;25(3):312\u201324. https:\/\/doi.org\/10.1016\/s1473-3099(24)00567-x.","journal-title":"Lancet Infect Dis"},{"key":"5300_CR57","doi-asserted-by":"publisher","unstructured":"Maitre T, Cottenet C, Godet J, et al. Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis. Eur Respir J. 2021;58(2). https:\/\/doi.org\/10.1183\/13993003.03345-2020.","DOI":"10.1183\/13993003.03345-2020"},{"issue":"5","key":"5300_CR58","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/s2666-5247(23)00031-9","volume":"4","author":"YN Liu","year":"2023","unstructured":"Liu YN, Zhang YF, Xu Q, et al. Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study. Lancet Microbe. 2023;4(5):e330\u20139. https:\/\/doi.org\/10.1016\/s2666-5247(23)00031-9.","journal-title":"Lancet Microbe"},{"key":"5300_CR59","doi-asserted-by":"publisher","unstructured":"Shankar J, Thakur R, Clemons KV, et al. Interplay of cytokines and chemokines in Aspergillosis. J Fungi (Basel). 2024;10(4). https:\/\/doi.org\/10.3390\/jof10040251.","DOI":"10.3390\/jof10040251"},{"key":"5300_CR60","doi-asserted-by":"publisher","first-page":"54","DOI":"10.19347\/j.cnki.2096-1413.201704025","volume":"3","author":"D Hui Zhou","year":"2017","unstructured":"Hui Zhou D, Zhou. Clinical investigation of nosocomial pulmonary fungal infections in the respiratory ward. Clin Res Pract. 2017;3:54\u20135. https:\/\/doi.org\/10.19347\/j.cnki.2096-1413.201704025.","journal-title":"Clin Res Pract"},{"issue":"7","key":"5300_CR61","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","volume":"23","author":"MS Lionakis","year":"2023","unstructured":"Lionakis MS, Drummond RA, Hohl TM. Immune responses to human fungal pathogens and therapeutic prospects. Nat Rev Immunol. 2023;23(7):433\u201352. https:\/\/doi.org\/10.1038\/s41577-022-00826-w.","journal-title":"Nat Rev Immunol"},{"issue":"48","key":"5300_CR62","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.3748\/wjg.v30.i48.5212","volume":"30","author":"S Patnaik","year":"2024","unstructured":"Patnaik S, Durairajan SSK, Singh AK, et al. Role of Candida species in pathogenesis, immune regulation, and prognostic tools for managing ulcerative colitis and Crohn\u2019s disease. World J Gastroenterol. 2024;30(48):5212\u201320. https:\/\/doi.org\/10.3748\/wjg.v30.i48.5212.","journal-title":"World J Gastroenterol"},{"key":"5300_CR63","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3760\/cma.j.issn.1671-0282.2021.04.004","volume":"30","author":"W Guo","year":"2021","unstructured":"Guo W, Zhang G, Ma Y. Expert consensus on the application of Procalcitonin in hierarchical management of lower respiratory tract infections in adults. Chin J Emerg Med. 2021;30:393\u2013401. https:\/\/doi.org\/10.3760\/cma.j.issn.1671-0282.2021.04.004.","journal-title":"Chin J Emerg Med"},{"key":"5300_CR64","doi-asserted-by":"publisher","unstructured":"Hardman M, Higgi S, Hanson L, et al. Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections. Microbiol Spectr. 2025;e0038225. https:\/\/doi.org\/10.1128\/spectrum.00382-25.","DOI":"10.1128\/spectrum.00382-25"},{"key":"5300_CR65","doi-asserted-by":"publisher","unstructured":"Barclay AM, Ninaber DK, Limpens R et al. Mycobacteria develop biofilms on airway epithelial cells and promote mucosal barrier disruption. iScience. 2024, 27 (11),111063. https:\/\/doi.org\/10.1016\/j.isci.2024.111063","DOI":"10.1016\/j.isci.2024.111063"},{"key":"5300_CR66","doi-asserted-by":"publisher","unstructured":"Carazo-Fern\u00e1ndez L, Gonz\u00e1lez-Cort\u00e9s C, L\u00f3pez-Medrano R et al. Mycobacterium avium complex infected cells promote growth of the pathogen Pseudomonas aeruginosa. Microb Pathog 2022,166,105549. https:\/\/doi.org\/10.1016\/j.micpath.2022.105549","DOI":"10.1016\/j.micpath.2022.105549"},{"key":"5300_CR67","doi-asserted-by":"publisher","unstructured":"Nickerson R, Thornton CS, Johnston B, et al. Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response. Front Immunol. 2024;15(1405376). https:\/\/doi.org\/10.3389\/fimmu.2024.1405376.","DOI":"10.3389\/fimmu.2024.1405376"},{"key":"5300_CR68","doi-asserted-by":"publisher","first-page":"625597","DOI":"10.3389\/fimmu.2021.625597","volume":"12","author":"C Moser","year":"2021","unstructured":"Moser C, Jensen P\u00d8, Thomsen K, et al. Immune responses to Pseudomonas aeruginosa biofilm infections. Front Immunol. 2021;12:625597. https:\/\/doi.org\/10.3389\/fimmu.2021.625597.","journal-title":"Front Immunol"},{"key":"5300_CR69","doi-asserted-by":"publisher","unstructured":"Cicchinelli S, Rosa F, Manca F, et al. The impact of smoking on microbiota: a narrative review. Biomedicines. 2023;11(4). https:\/\/doi.org\/10.3390\/biomedicines11041144.","DOI":"10.3390\/biomedicines11041144"},{"issue":"1","key":"5300_CR70","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12931-019-1246-0","volume":"20","author":"KJ Li","year":"2019","unstructured":"Li KJ, Chen ZL, Huang Y, et al. Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety. Respir Res. 2019;20(1):272. https:\/\/doi.org\/10.1186\/s12931-019-1246-0.","journal-title":"Respir Res"},{"issue":"9","key":"5300_CR71","doi-asserted-by":"publisher","first-page":"e0038225","DOI":"10.1128\/spectrum.00382-25","volume":"13","author":"M Hardman","year":"2025","unstructured":"Hardman M, Higgi S, Hanson L, et al. Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections. Microbiol Spectr. 2025;13(9):e0038225. https:\/\/doi.org\/10.1128\/spectrum.00382-25.","journal-title":"Microbiol Spectr"},{"issue":"9","key":"5300_CR72","doi-asserted-by":"publisher","first-page":"e0050923","DOI":"10.1128\/iai.00509-23","volume":"92","author":"BP Darwitz","year":"2024","unstructured":"Darwitz BP, Genito CJ, Thurlow LR. Triple threat: how diabetes results in worsened bacterial infections. Infect Immun. 2024;92(9):e0050923. https:\/\/doi.org\/10.1128\/iai.00509-23.","journal-title":"Infect Immun"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05300-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:02:50Z","timestamp":1789995770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05300-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5300"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05300-4","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was conducted among hospitalized patients and was approved by the Ethics Committee of the 8th Medical Center of the PLA General Hospital (approval number: 309202109061503). This was a retrospective study that involved no patient identifiers; therefore, the Ethics Committee of the 8th Medical Center of PLA General Hospital waived the requirement for written informed consent. However, our study complies with Helsinki\u2032s Ethical Principles for Medical Research.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"823"}}